VKTX

Executive Summary Viking Therapeutics remains entirely devoid of commercialized products and generates zero revenue, making its valuation highly dependent on…

Viking Therapeutics, inc (NASDAQ: VKTX) Q2 2022 Earnings Conference

Viking Therapeutics, inc (NASDAQ: VKTX) Q1 2022 Earnings Conference

Viking Therapeutics, inc (NASDAQ: VKTX) Q4 2021 Earnings Conference

Viking Therapeutics, inc (NASDAQ: VKTX) Q3 2021 Earnings Conference

Viking Therapeutics, inc (NASDAQ: VKTX) Q2 2021 Earnings Conference

Viking Therapeutics Inc  (VKTX) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Stephanie Diaz — Manager, Investor Relations Brian Lian — President…

Viking Therapeutics Inc  (NASDAQ: VKTX) Q4 2019 Earnings Conference Call February 26, 2020 Corporate Participants: Stephanie C. Diaz — President and Chief Executive…

— Viking Therapeutics Inc. (NASDAQ: VKTX) reported Q3 2019 loss of $0.08 per share, vs. a loss of $0.13 expected.…